Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow-to-Debt Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of ₫-135.66 Billion could theoretically repay 0% of its total liabilities (₫870.62 Billion) in one year. See DBD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. For the full cash flow conversion analysis, see Binh Dinh Pharmaceutical and Medical Equ operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year debt coverage analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. Check DBD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | ₫615.19 Billion | ₫862.89 Billion | ▲ +62.4% |
| 2024 | 0.44x | ₫264.73 Billion | ₫603.07 Billion | ▼ -17.0% |
| 2023 | 0.53x | ₫293.99 Billion | ₫556.07 Billion | ▲ +73.2% |
| 2022 | 0.31x | ₫165.01 Billion | ₫540.58 Billion | ▲ +8.8% |
| 2021 | 0.28x | ₫117.57 Billion | ₫418.97 Billion | ▼ -40.9% |
| 2020 | 0.47x | ₫212.91 Billion | ₫448.78 Billion | — |